Table 3. EBV DNA loads in peripheral... | American Society of Hematology

Table 3.

EBV DNA loads in peripheral blood of 6 PTLD patients and 8 non-PTLD LTx recipients

Patient no.	PTLD, mo	First EBV⁺ sample, mo/d after LTx	Follow-up period, mo	Total samples		EBV DNA load range, copies per mL blood	Samples before PTLD		EBV DNA load at PTLD diagnosis, copies per mL blood
Patient no.	PTLD, mo	First EBV⁺ sample, mo/d after LTx	Follow-up period, mo	No. tested	Above Q-PCR cut-off value, no. (%)	EBV DNA load range, copies per mL blood	No. tested	Above Q-PCR cut-off value, no. (%)	EBV DNA load at PTLD diagnosis, copies per mL blood
1	2	1 mo	13	29	23 (79)	3400-308 000	7	4 (57)	66 600, 95 400, 24 800
2	19	2 mo	19	38	34 (89)	2400-98 000	31	27 (87)	15 000
3	32	—	15	15	1 (6)	5500	6	0 (0)	<2000
4	55	48^3-150mo	17	23	19 (83)	2700-108 800	6	6 (100)	29 800^3-151
5	67	61^3-150 mo	13	19	5 (26)	2400-11 900	4	4 (100)	4500
6	78	7^3-150mo	13	17	14 (82)	2000-13 600	9	9 (100)	7000
7	—	11-25 d	15	16	3 (19)	4500-6600	—	—	—
8	—	3 mo	14	13	1 (8)	4000	—	—	—
9	—	—	26	36	0 (0)	—	—	—	—
10	—	—	6	17	0 (0)	—	—	—	—
11	—	—	8	9	0 (0)	—	—	—	—
12	—	—	8	8	0 (0)	—	—	—	—
13	—	—	8	8	0 (0)	—	—	—	—
14	—	—	6	10	0 (0)	—	—	—	—

Patient no.	PTLD, mo	First EBV⁺ sample, mo/d after LTx	Follow-up period, mo	Total samples		EBV DNA load range, copies per mL blood	Samples before PTLD		EBV DNA load at PTLD diagnosis, copies per mL blood
Patient no.	PTLD, mo	First EBV⁺ sample, mo/d after LTx	Follow-up period, mo	No. tested	Above Q-PCR cut-off value, no. (%)	EBV DNA load range, copies per mL blood	No. tested	Above Q-PCR cut-off value, no. (%)	EBV DNA load at PTLD diagnosis, copies per mL blood
1	2	1 mo	13	29	23 (79)	3400-308 000	7	4 (57)	66 600, 95 400, 24 800
2	19	2 mo	19	38	34 (89)	2400-98 000	31	27 (87)	15 000
3	32	—	15	15	1 (6)	5500	6	0 (0)	<2000
4	55	48^3-150mo	17	23	19 (83)	2700-108 800	6	6 (100)	29 800^3-151
5	67	61^3-150 mo	13	19	5 (26)	2400-11 900	4	4 (100)	4500
6	78	7^3-150mo	13	17	14 (82)	2000-13 600	9	9 (100)	7000
7	—	11-25 d	15	16	3 (19)	4500-6600	—	—	—
8	—	3 mo	14	13	1 (8)	4000	—	—	—
9	—	—	26	36	0 (0)	—	—	—	—
10	—	—	6	17	0 (0)	—	—	—	—
11	—	—	8	9	0 (0)	—	—	—	—
12	—	—	8	8	0 (0)	—	—	—	—
13	—	—	8	8	0 (0)	—	—	—	—
14	—	—	6	10	0 (0)	—	—	—	—

PTLD is given in months after LTx. The patient follow-up period started at LTx.

Follow-up started at first collected positive sample.

Indicates the value of the last sample obtained before PTLD (3 weeks prior to diagnosis) because PTLD was diagnosed elsewhere.